Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2010
10/28/2010US20100273660 ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORS
10/28/2010US20100273659 Nitrilases, Nucleic Acids Encoding Them and Methods for Making and Using Them
10/28/2010US20100273658 Methods for Assaying Gene Imprinting and Methylated CpG Islands
10/28/2010US20100273238 Cellular Permissivity Factor for Viruses and Uses Thereof
10/28/2010US20100273209 Co2 optical sensor for detection and enumeration of microorganisms
10/28/2010US20100273208 Microorganism testing apparatus
10/28/2010US20100273207 Methods for Diagnosis of Sepsis and Risk of Death
10/28/2010US20100273206 Diagnostic in vitro method for assessing von willebrand disease and increased bleeding risk associated with von willebrand disease and acquired or congenital disorders of platelet function
10/28/2010US20100273205 Magnetic resonance imaging contrast agents
10/28/2010US20100273204 Methods for monitoring the efficacy of anti-il-2r antibodies in multiple sclerosis patients
10/28/2010US20100273203 Methods and compositions for detecting metabolites
10/28/2010US20100273202 Codon-optimized nucleic acid for coding apo-clytin-ii and method for using the same
10/28/2010US20100273201 Acetolactate Synthase (ALS) Selectable Marker from Trichoderma reesei
10/28/2010US20100273200 In-Vitro Model of Blood-Brain Barrier, In-Vitro Model of Diseased Blood-Brain Barrier, and Drug Screening Method, Analysis Method for Functions of Diseased Blood-Brain Barrier, and Analysis Method for Pathogenesis Using the Same
10/28/2010US20100273199 Methods and Compositions
10/28/2010US20100273198 Engineering enzymatically susceptible proteins
10/28/2010US20100273197 Smart enzyme-containing catalytic peelable coatings
10/28/2010US20100273196 System and Method for Evaluating Blood-Neural Barrier Permeability
10/28/2010US20100273195 Skin aging-preventing or improving agent
10/28/2010US20100273184 Device for magnetic detection of individual particles in a microfluid channel
10/28/2010US20100273183 Diagnostic assay for anti-von willebrand factor cleaving protease (adamts13) antibodies
10/28/2010US20100273181 Methods for the detection of glycated hemoglobin
10/28/2010US20100273178 Affinity selected signature peptides for protein identification and quantification
10/28/2010US20100273176 Method of judging risk for onset of drug-induced granulocytopenia
10/28/2010US20100273175 Method of judging risk for onset of drug-induced granulocytopenia
10/28/2010US20100273174 Antibodies to tumor associated proteins
10/28/2010US20100273173 Method for amplifying target nucleic acid sequence and probe used for the same
10/28/2010US20100273172 Micrornas expression signature for determination of tumors origin
10/28/2010US20100273171 Global gene expression analysis of human bronchial epithelial cells exposed to cigarette smoke, smoke condensates, or components thereof
10/28/2010US20100273170 Method and device for preparing biological samples for analysis
10/28/2010US20100273169 Quantitative pcr-based compositions and methods for the diagnosis of invasive pulmonary aspergillosis
10/28/2010US20100273168 Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer
10/28/2010US20100273167 Methods for determining prenatal alcohol exposure
10/28/2010US20100273166 biosensor device and method of sequencing biological particles
10/28/2010US20100273165 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
10/28/2010US20100273164 Targeted and Whole-Genome Technologies to Profile DNA Cytosine Methylation
10/28/2010US20100273163 Methods for Identifying Agents that Inhibit Cell Migration, Promote Cell Adhesion and Prevent Metastasis
10/28/2010US20100273162 Rapid detection of microorganisms
10/28/2010US20100273161 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin
10/28/2010US20100273160 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
10/28/2010US20100273159 Nested Multiplex Amplification Method for Identification of Multiple Biological Entities
10/28/2010US20100273158 HIN-1, A Tumor Suppressor Gene
10/28/2010US20100273157 System and Method for Authentication or Identification of Bio-Artifacts Related to President Abraham Lincoln
10/28/2010US20100273156 Sequences and methods for detecting influenza a and influenza b virus
10/28/2010US20100273155 Determination of quality features in agricultural and horticultural crops
10/28/2010US20100273154 Novel glycosyltransferases and polynucleotides encoding the same
10/28/2010US20100273153 Genetic diagnosis of depression
10/28/2010US20100273152 Method of identifying individuals at risk of thiopurine drug resistance and intolerance
10/28/2010US20100273151 Genome-wide analysis of palindrome formation and dna methylation
10/28/2010US20100273150 Single molecule-format bioluminescent probe
10/28/2010US20100273149 Photosynthetic hydrogen production from the green alga chlamydomonas reinhardtii
10/28/2010US20100273148 Urine markers for detection of bladder cancer
10/28/2010US20100273147 Medical diagnostic system and methods
10/28/2010US20100273146 TB resistance assay
10/28/2010US20100273145 Assay method utilizing polynucleotide sequences
10/28/2010US20100273144 Novel use of grp 94 in virus infection
10/28/2010US20100273143 Discriminatory positive/extraction control dna
10/28/2010US20100273142 Multi-compartment device with magnetic particles
10/28/2010US20100272758 Viable non-toxic gram-negative bacteria
10/28/2010US20100272746 Lipoparticle comprising a protein and methods of making and using the same
10/28/2010US20100272741 Immunity to folate receptors
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272725 Neisserial antigens
10/28/2010US20100272724 Binding molecules capable of neutralizing rabies virus and uses thereof
10/28/2010US20100272713 Genetic Markers Associated with Endometriosis and Use Thereof
10/28/2010US20100272712 Jnk3 as a target for the treatment of angiogenesis-related diseases
10/28/2010US20100272709 Cathepsin l mediated diseases and associated methods and products
10/28/2010US20100272707 Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof
10/28/2010US20100272706 Antivirals
10/28/2010US20100272694 Clinic compliant method for banking human placental mesenchymal cells
10/28/2010US20100272651 Method for assessing potential for tumor development and metastasis
10/28/2010US20100272650 Semiconductor nanoparticle, and fluorescent labeling substance and molecule/cell imaging method by use thereof
10/28/2010US20100272648 Methods of Identifying Improved NMDA Receptor Antagonists
10/28/2010US20100272647 Receptor
10/28/2010US20100270177 Method of measuring blood component, sensor used in the method, and measuring device
10/28/2010US20100270152 Enzymatic reagent ink
10/28/2010US20100270151 Method for manufacturing an enzymatic reagent ink
10/28/2010CA2795268A1 Methods for obtaining fetal genetic material
10/28/2010CA2759831A1 Compositions for use in security marking
10/28/2010CA2759698A1 Bin1 as a prognostic marker in cardiovascular disease
10/28/2010CA2759681A1 Selective detection of bordetella species
10/28/2010CA2759457A1 Association of htra1 mutations and familial ischemic cerebral small-vessel disease
10/28/2010CA2759443A1 Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
10/28/2010CA2759417A1 Prognostic molecular signature of sarcomas, and uses thereof
10/28/2010CA2759325A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
10/28/2010CA2759312A1 Method of diagnosing bladder cancer
10/28/2010CA2759211A1 Cellular assay employing detectable protein
10/28/2010CA2759141A1 Hp1alpha as a prognostic marker in human cancer
10/28/2010CA2759079A1 Breast cancer susceptibility gene gt198 and uses thereof
10/28/2010CA2759028A1 Biological specimen collection/transport compositions and methods
10/28/2010CA2757764A1 Cancer antigen helper peptide
10/27/2010EP2243843A1 HP1alpha as a prognostic marker in human cancer
10/27/2010EP2243842A1 DCLK1 and cognitive ability and cognitive performance
10/27/2010EP2243841A1 Method for manufacturing an enzymatic reagent ink
10/27/2010EP2243840A1 Enzymatic reagent ink
10/27/2010EP2243834A1 Assessment of risk for colorectal cancer
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243493A1 Immunopotentiative composition
1 ... 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 ... 3003